In closing its therapeutics division and laying off 200 people, 23andMe ended an audacious bet it made nearly a decade ago — ...

This year has seen several biopharma companies drop Alzheimer’s and Parkinson’s disease programs, but experts say plenty are ...

A study of Gila monster venom helped start the revolution in weight-loss drugs. But scientists think that’s just the ...

A large trial showed that semaglutide, sold as Ozempic for diabetes and as Wegovy for obesity, was better than any current ...

Geroscience has a long way to go, but there are four FDA-approved drugs that have shown promise to “target the process of ...

Academy Award winning actor Anne Hathaway is celebrating her 42nd birthday today and on the occasion, we have a list of her ...

Powered by its popular GLP-1 weight loss drugs, Eli Lilly's stock (NYSE: LLY) has had a strong run this year, up more than 55 ...

A new study shows that a common glaucoma drug cleared tau build-up and reduced signs of neurodegenerative disease in zebrafish and mice.

A group of Florida seniors were told to evacuate their homes for Hurricane Helene, but they haven’t been allowed to return in ...

Q3 2024 Earnings Call Transcript November 8, 2024 Amneal Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is ...

Neurocrine Biosciences, Inc.'s potential for growth in the biopharma sector is strong despite recent setbacks, making its ...